These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7935986)

  • 1. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
    Beketić-Oresković L; Osmak M
    Neoplasma; 1994; 41(3):171-6. PubMed ID: 7935986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L; Osmak M; Jaksić M
    Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
    Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
    Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum (II) or vincristine sulfate.
    Osmak M
    Neoplasma; 1992; 39(3):197-202. PubMed ID: 1528326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.
    Beketic-Oreskovic L; Osmak M
    Cancer Chemother Pharmacol; 1995; 35(4):327-33. PubMed ID: 7828276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
    Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI
    Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
    Yokomizo A; Ono M; Nanri H; Makino Y; Ohga T; Wada M; Okamoto T; Yodoi J; Kuwano M; Kohno K
    Cancer Res; 1995 Oct; 55(19):4293-6. PubMed ID: 7671238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Up-regulation of human chorionic gonadotropin alpha subunit gene and human mitochondrial cytochrome c oxidase subunit II gene in cis-Diamminedichloroplatinum(II)-resistant human head and neck squamous carcinoma cells].
    Higuchi E
    Hokkaido Igaku Zasshi; 1999 May; 74(3):231-8. PubMed ID: 10422566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A; Weixel K; Saijo N
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
    Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
    Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
    Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
    Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.